, NCCN Panelists included: • Arun Krishna, PhD, Vice-President, US Franchise Head & Lung Cancer, featured on the panel. Dr. Krishna discussed the importance of lung cancer screening because the U.S., challenges and focuses on education and processes to improve screening uptake. Mobile lung and mammography
https://www.nccn.org/docs/default-source/oncology-policy-program/nccn-sosf-2024-thirteenth-annual-summary.pdf?sfvrsn=5346b0f5_1Patient Advocate SVP Patient Services and Health Care Delivery LUNGevity F i n d i n g
https://www.nccn.org/docs/default-source/patient-resources/webinar-flyer/download-a-printable-flyer-about-clinical-trials-to-share-with-others!.pdf?sfvrsn=3736bfe0_1Version: 1.2025 Non-Small Cell Lung Cancer, Small Cell Lung Cancer Version: 4.2025
https://www.nccn.org/guidelines/category_1care and outcomes. The first disease types available were: Acute Leukemia and Breast, Colon, Lung
https://www.nccn.org/home/about/nccn-history/30-years-of-nccnto Improve Lung Cancer Screening Among Black Veterans Ravi Parikh, MD, MPP, The Abramson
https://www.nccn.org/education-research/nccn-oncology-research-program/young-investigator-awardsNeelima Navuluri, MD, MPH, Duke Cancer Institute Intervention Mapping to Improve Lung Cancer
https://www.nccn.org/patientresources/patient-resources/nccn-foundation/young-investigator-awardsto the Management of Resectable Non-Small Cell Lung Cancer Earn CE credit. EVENT
https://www.nccn.org/education-research/educational-events-and-programs/calendar-of-eventsof Resectable Non-Small Cell Lung Cancer 1.00 AAPA Category 1 CME credit 1.00 ACPE contact hours 1.00
https://www.nccn.org/lms_redirectinterested in giving toward specific areas of cancer (i.e. breast cancer, lung cancer, etc.) should
https://www.nccn.org/patientresources/patient-resources/nccn-foundation/ways-to-givethe Date! NCCN 2025 Lung Cancer Congress Earn CE credit. | In-person and virtual attendance
https://www.nccn.org/members/member-institution-portal/member-institution-toolkitNeuroendocrine and Adrenal Tumors Version 1.2025 Non-Small Cell Lung Cancer, Version 2.2025 Small Bowel Adenocarcinoma Version 3.2025 Small Cell Lung Cancer
https://www.nccn.org/guidelines/guidelines-with-evidence-blocks, BCOP Mayo Clinic Comprehensive Cancer Center Non-Small Cell Lung, Institute at the University of Utah Small Cell Lung Cancer Sally
https://www.nccn.org/compendia-templates/nccn-templates-main/nccn-chemotherapy-order-reviewer-engagementbased on the WHO EML for cancers with the highest incidence in LLMICs. These cancers include lung
https://www.nccn.org/docs/default-source/global/the-impact-of-policy-regulation-on-guideline-concordant-care-globally-summary-article.pdf?sfvrsn=b36df21a_3Prostate Cancer Lung Cancer 13 © National Comprehensive Cancer Network, Inc. 2021, All Rights, Prevalence Va r i e s G e o g raphically 2017 Medicare Population 25 Lung Cancer Prostate Cancer
https://www.nccn.org/docs/default-source/oncology-policy-program/2021_elevating_cancer_equity_webinar_slides.pdf?sfvrsn=e11f66e4_4, e.g.: …MCL, mantle cell lymphoma; NCCN, National Comprehensive Cancer Network; SCLC, small cell lung
https://www.nccn.org/guidelines/submissions-licensing-and-permissions/permission-to-cite-or-use-nccn-content-faqGuidelines; NCCN Guidelines for Patients: Lung Cancer Screening; NCCN Guidelines for Detection
https://www.nccn.org/business-policy/business/employer-resources/employer-toolkitBoxed WARNINGS for Interstitial Lung Disease and Embryo-Fetal Toxicity, and click here for Medication
https://www.nccn.org/docs/default-source/business-policy/rrr-pdf-2021.pdf?sfvrsn=99028107_8